Please use this identifier to cite or link to this item: http://hdl.handle.net/11455/96070
標題: Variations in the efficacy of resistant maltodextrin formula on body fat reduction in rats fed different high-fat models
難消化性麥芽糊精配方改善體脂功效之評估
作者: Hui-Fang Chu
朱慧芳
關鍵字: 肥胖
膳食纖維
體脂肪
難消化性麥芽糊精
菊糖
obesity
dietary fiber
body fat
resistant maltodextrin
inulin
引用: Abete I, Parra MD, Zulet MA, Martínez JA. 2006. Different dietary strategies for weight loss in obesity: role of energy and macronutrient content. Nutr Res Rev 19, 5-17. Adisakwattana S, Intrawangso J, Hemrid A, Chanathong B, Mäkynen K. 2012. Extracts of edible plants inhibit pancreatic lipase, cholesterol esterase and cholesterol micellization, and bind bile acids. Food Technol Biotechnol 50, 11-16. Ahn J, Lee H, Kim S, Park J, Ha T. 2008. The anti-obesity effect of quercetin is mediated by the AMPK and MAPK signaling pathways. Biochem Biophys Res Commun 373, 545-549. Akande KE, Doma UD, Agu HO, Adamu HM. 2010. Major antinutrients found in plant protein sources: Their effect on nutrition. Pak J N 9, 827-832. Aoyama T, Fukui K, Takamatsu K, Hashimoto Y, Yamamoto T. 2000. Soy protein isolate and its hydrolysate reduce body fat of dietary obese rats and genetically obese mice (Yellow KK). Nutr 16, 349-354. Assini JM, Mulvill EE, Hurf MW. 2013. Citrus flavonoids and lipid metabolism. Curr Opin Lipidol 24, 34-40 Astrup A, Kristensen M, Gregersen NT, Belza A, Lorenzen JK, Due A, Larsen TM. 2010. Can bioactive foods affect obesity? Ann N Y Acad Sci 1190, 25-41. Axen KV, Dikeakos A, Sclafani A. 2003. High dietary Fat promotes syndrome X in nonobese rats. J Nutr 133, 2244-2249. Aydin S. 2014. Three new players in energy regulation: Preptin, adropin and irisin. Peptides 56, 94–110. Bassoli BK, Cassolla P, Borba-Murad GR, Constantin J, Salgueiro-Pagadigorria CL, Bazotte RB, da Silva RS, de Souza HM. 2008. Chlorogenic acid reduces the plasma glucose peak in the oral glucose tolerance test: effects on hepatic glucose release and glycaemia. Cell Biochem Funct 26, 320-328. Beaglehole R, Bonita R, Alleyne G, Horton R, Li L, Lincoln P, Mbanya, JC, McKee, M., Moodie, R., Nishtar, S. 2011. UN high-level meeting on non-communicable diseases: addressing four questions. The Lancet 378, 449-455. Belza A, Frandsen E, Kondrup J. 2007. Body fat loss achieved by stimulation of thermogenesis by a combination of bioactive food ingredients: A placebo-controlled, double-blind 8-week intervention in obese subjects. 31, 121-130. Birari RB, Bhutani KK. 2007. Pancreatic lipase inhibitors from natural sources: unexplored potential. Drug Discov Today 12, 879-889. Bordicchia M, Pocognoli A, D'Anzeo M, Siquini W, Minardi D, Muzzonigro G, Dessì-Fulgheri P, Sarzani R. 2014. Nebivolol induces, via _3 adrenergic receptor, lipolysis, uncoupling protein 1, and reduction of lipid droplet size in human adipocytes. J Hypertens 32, 389–396. Bray GA, Popkin BM. 1998. Dietary fat intake does affect obesity! Am. J Clin Nutr 68, 1157-1173. Brown L, Rosner B, Willett WW, Sacks FM. 1999. Cholesterol-lowering effects of dietary fiber: a meta-analysis. Am J Clin Nutr 69, 30-42. Buettner R, Parhofer KG, Woenckhaus M, Wrede, CE, Kunz-Schughart, LA, Schölmerich J, Bollheimer LC. 2006. Defining high-fat-diet rat models: metabolic and molecular effects of different fat types. J Mol Endocrinol 36, 485-501. Cha KH, Song DG, Kim SM, Pan CH. 2012. Inhibition of gastrointestinal lipolysis by green tea, coffee, and gomchui (Ligularia fischeri) tea polyphenols during simulated digestion. J Agric Food Chem 60, 7152-7157. Chambers L, McCrickerd K, Yeomans MR. 2015. Optimising foods for satiety. Trends Food Sci Technol 41, 149-160. Choo JJ. 2003. Green tea reduces body fat accretion caused by high-fat diet in rats through β-adrenoceptor activation of thermogenesis in browna dipose tissue. J Nutr Biochem 11, 671-676. Demigne C, Morand C, Levrat MA, Besson C, Moundras C, Remesey C. 1995. Effect of propionate on fatty acid and cholesterol synthesis and on acetate metabolism in isolated rat hepatocytes. Br J Nutr 74, 209-219. Dos Santos MD, Almeida MC, Lopes NP, de Souza GE. 2006. Evaluation of the antiinflammatory, analgesic and antipyretic activities of the naturalpolyphenol chlorogenic acid. Biol Pharm Bull 29, 2236-2240. Fiordaliso M, Kok N, Desager JP, Goethals F, Deboyser D, Roberfroid M, Delzenne N. 1995. Dietary oligofructose lowers serum and VLDL concentrations of triglycerides, phopsholipids and cholesterol in rats. Lipids 30, 163-167. Flickinger EA., Wolf BW, Garleb KA., Chow J, Leyer GJ, Johns PW, Fahey GC. 2000. Glucose-based oligosaccharides exhibit different in vitro fermentation patterns and affect in vivo apparent nutrient digestibility and microbial populations in dogs. J. Nutr 130, 1267-1273. Folch J, Less M, Sloane-Stanley, G. 1957. A simple method for the isolation and purification of total lipids from animal tissues. J biol Chem 226, 497-509. Garlick PJ, Clugston GA, Waterlow JC. 1980. Influence of low-energy diets on whole-body protein turnover in obese subjects. Am J Physiol 238, E235-244. Gordon DT. 2007. The effects of resistant maltodextrin on blood glucose, insulin and triacylglyceride levels, and fat accumulation after meal feeding in humans. Salovaara Hannu, Gates Fred, & Tenkanen Maija. Dietary Fibre: Components and Functions (p 305-322). The Netherlands: Wageningen Academic Publishers. Hariri N, Thibault L. 2010. High-fat diet-induced obesity in animal models. Nutr Res Rev Dec 23, 270-299. Harrold J, Williams G, Widdowson P. 2000. Early leptin response to a palatable diet predicts dietary obesity in rats: key role of melanocortin-4 receptors in the ventromedial hypothalamic nucleus. J. Neurochem 74, 1224-1228. Hashizume C, Kishimoto Y, Kanahori S, Yamamoto T, Okuma K, Yamamoto K. 2012. Improvement effect of resistant maltodextrin in humans with metabolic syndrome by continuous administration. J Nutr Sci Vitaminol (Tokyo) 58, 423-430. Hashizume C, Kishimoto Y, Kanahori S, Yamamoto T, Okuma K, Yamamoto K., 2012. Improvement effect of resistant maltodextrin in humans with metabolic syndrome by continuous administration. Journal of Nutritional Science and Vitaminology (Tokyo) 58(6), 423-430. Hashizume C. Okuma K. 2009. Fibersol-2 resistant maltodextrin: functional dietary fiber ingredient. In Cho, S. S. and Samuel, P. Eds., Fiber ingredients: food applications and health benefits. Taylor & Francis. USA, 61-78 Heck AM, Yanovski JA, Calis KA. 2000. Orlistat, a new lipase inhibitor for the management of obesity. Pharmacotherapy 20, 270-279. Heson LC, Heber D. 1983. Whole Body Protein Breakdown Rates and Hormonal Adaptation in Fasted Obese Subjects*. The Journal of Clinical Endocrinology & Metabolism 57, 316-319. HHP. Harvard Health Publications. 2010. Taking aim at belly fat. (http://www.health.harvard.edu/staying-healthy/taking-aim-at-belly-fat) HHP. Harvard Health Publications. 2015a. The type of fat you eat matters! (http://www.health.harvard.edu/blog/the-type-of-fat-you-eat-matters-201509228333) HHP. Harvard Health Publications. 2015b. Abdominal fat and what to do about it. (http://www.health.harvard.edu/staying-healthy/abdominal-fat-and-what-to-do-about-it) HHP. Harvard Health Publications. 2017. Abdominal obesity and your health. (http://www.health.harvard.edu/family-health-guide/abdominal-obesity-and-your-health) Hoffer LJ, Bistrian BR, Young V, Blackburn G, Matthews D. 1984. Metabolic effects of very low calorie weight reduction diets. J Clin Invest 73, 750-758. Hsu CL, Wu CH, Huang SL, Yen GC. 2009. Phenolic Compounds Rutin and o-Coumaric Acid Ameliorate Obesity Induced by High-Fat Diet in Rats. J. Agric. Food Chem 57, 425-431. Iqbal J, Hussain MM. 2009. Intestinal lipid absorption. Am J Physiol Endocrinol Metab 296, E1183-1194. Jen KL, Buison A, Pellizzon M, Ordiz Jr F, Santa Ana L, Brown J. 2003. Differential effects of fatty acids and exercise on body weight regulation and metabolism in female Wistar rats. Exp. Biol. Med. (Maywood) 228, 843-849. Kaila B, Raman M. 2008. Obesity: a review of pathogenesis and management strategies. Can J Gastroenterol 22, 61-68. Kajimura S, Saito M. 2014. A new era in brown adipose tissue biology: Molecular control of brown fat development and energy homeostasis. Annu Rev Physiol 76, 225–249. Kang HJ, Seo HA, Go Y, Oh CJ, Jeoung NH, Park KG, Lee IK. 2013. Dimethylfumarate suppresses adipogenic differentiation in 3T3-L1 preadipocytes through inhibition of STAT3 activity. PLoS ONE 8, e61411. Kasai H, Fukada S, Yamaizumi Z, Sugie S, Mori H., 2000. Action of chlorogenic acid in vegetables and fruits as an inhibitor of 8-hydroxydeoxyguanosine formation in vitro and in a rat carcinogenesis model. Food Chem Toxicol 38, 467-471. Kazuo KH, Mogi A, Matsumoto Y, Takita T. 2005. Effect of caffeine on the body fat and metabolism of rats fed on a high-fat diet. Biosci Biotech Bioch 69, 2219-2223. Keller & Heckman LLP. 2012. GRAS Notification for roquette's resistant dextrin. college park: U.S. Food and Drug Administration. Kim SO, Yun JS, Lee BE, Hahm HD, Shim I, Lee H. 2004. Hypolipidemic effects of crude extract of adlay seed (Coix lachrymajobi var. mayuen) in obesity rat fed high fat diet : Relations of TNF-a and leptin mRNA expressions and serum lipid levels. Life. Sci 75 1391-1404. Kishimoto Y, Yoshikawa Y, Miyazato S, Oga H, Yamada T, Tagami H, Hashizume C, Yamamoto K. 2009. Effect of resistant maltodextrin on digestion and absorption of lipids. J Health Sci 55, 838-844. Kola B, Grossman A, Korbonits M. 2008. The role of AMP-activated protein kinase in obesity. Front Horm Res 36, 198-211. Kopelman PG. 2000. Obesity as a medical problem. Nature 404, 635-643. Kortt MA, Langley PC, Cox ER. 1998. A review of cost-of-illness studies on obesity. Clin Ther 20, 772-779. Kurowska EM, Manthey JA. 2004. Hypolipodemic effects and absorption of citrus polymethoxylated flavones in hamsters with diet-induced hypercholesterolemia. J Agric Food Chem 52, 2879- 2886. Kusunoki M, Hara T, Tsutsumi K, Nakamura T, Miyata T, Sakakibara F. 2000. The lipoprotein lipase activator, NO-1886, suppresses fat accumulation and insulin resistance in rats fed a high-fat diet. Diabetologia 43, 875-880. Li S, Pan MH, Lo C.Y, Tan D, Wang Y, Shahidid F, Ho CT. 2009. Chemistry and health effects of polymethoxyflavones and hydroxylated polymethoxyflavones. J Funct Foods 1, 2-12. Marrelli M, Loizzo MR, Nicoletti M, Menichini F, Conforti F. 2013. Inhibition of key enzymes linked to obesity by preparations from mediterranean dietary plants: Effects on -amylase and pancreatic lipase activities. Plant Foods Hum Nutr 68, 340-346. Matsuda J, Hosoda K, Itoh H, Son C, Doi K, Tanaka T. 1997. Cloning of rat uncoupling protein-3 and uncoupling protein-2 cDNAs: their gene expression in rats fed high-fat diet. Febs. Lett 418, 200-204. Meng S, Cao J, Feng Q, Peng J, Hu Y. 2013. Roles of chlorogenic acid on regulating glucose and lipids metabolism: a review. Evid Based Complement Alternat Med, 11. Mensink MA, Frijlink HW, K van der Voort Maarschalk, WLJ. Hinrichs. 2015. Inulin, a flexible oligosaccharide I: Review of its physicochemical characteristics. Carbohydr Polym 130, 405-419. Miyata Y, Tanaka H, Shimada A, Sato T, Ito A, Yamanouchi T, Kosano H. 2011. Regulation of adipocytokine secretion and adipocyte hypertrophy by polymethoxyflavonoids, nobiletin and tangeretin. Life Sci 28, 613-618. Morton GJ, Meek TH, Schwartz MW. 2014. Neurobiology of food intake in health and disease. Nat Rev Neurosc 15, 367-378. Mulzer M, Tiegs BJ, Wang Y, Coates GW, O'Doherty GA. 2014. Total synthesis of tetrahydrolipstatin and stereoisomers via a highly regio- and diastereoselective carbonylation of epoxyhomoallylic alcohols. J Am Chem Soc 136, 10814–10820. Narita Y, Iwai K, Fukunaga T, Nakagiri O. 2012. Inhibitory activity of chlorogenic acids in decaffeinated green coffee beans against porcinepancreas lipase and effect of a decaffeinated green coffee bean extract on an emulsion of oliveoil. Biosci Biotechnol Biochem 76, 2329-2331. National Research Council. 1995. Nutrient Requirements of Laboratory Animals, 4th ed. National Academy Press, Washington, DC. Nishida C, Uauy R, Kumanyika S, Shetty P. 2004. The joint WHO/FAO expert consultation on diet, nutrition and the prevention of chronic diseases: process, product and policy implications. Public Health Nutr 7, 245-250. O'Neill HM, Holloway GP, Steinberg GR. 2013 AMPK regulation of fatty acid metabolism and mitochondrial biogenesis: Implications for obesity. Mol Cell Endocrinol 366, 135-151. OECD., 2012. Policy Brief: OECD Obesity Update 2012. Paris: The Organisation for Economic Co-operation and Development. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal, KM. 2006. Prevalence of overweight and obesity in the United States, 1999-2004. Jama 295, 1549-1555. Ohkuma K, Matsuda I, Katta Y, Hanno Y. 1990. Pyrolysis of starch and its digestibility by enzyme. J. Jpn. Soc. Starch Sci 37, 104-114. Okuma K, Kishimoto Y. 2004. Effects of resistant maltodextrin on metabolism of glucose and lipids. Dietary fibre: bio-active carbohydrates for food and feed. Dietary Fibre 2003 Conference, The Netherlands, 18-21 May 2003. (p 230). Wageningen: Wageningen Universiteit (Wageningen University). Onda K, Horik, N, Suzuki T, Hirano T. 2012. Polymethoxyflavonoids tangeretin and nobiletin increase glucose uptake in murine adipocytes. Phytother Res 27, 312-316 Pan MH, Lai CS, Wu JC, Ho CT, 2011. Molecular mechanisms for chemoprevention of colorectal cancer by natural dietary compounds. Mol Nutr Food Res Jan 55, 32-45. Papathanasopoulos A, Camilleri M. 2010. Dietary fiber supplements: Effects in obesity and metabolic syndrome and relationship to gastrointestinal functions. Gastroenterology 138, 65-72. Peluso RM, Winters AT, Shanahan FM, Banz WJ. 2000. A cooperative interaction between soy protein and its isoflavone-enriched fraction lowers hepatic lipids in male obese zucker rats and reduces blood platelet sensitivity in male sprague-dawley rats. J Nutr 130, 2333-2342. Pencharz P, Motil K, Parsons H, Duffy B. 1980. The effect of an energy-restricted diet on the protein metabolism of obese adolescents: nitrogen-balance and whole-body nitrogen turnover. Clin Sci (Lond) 59, 13-18. Petterino C, Argentino-Storino A. 2006. Clinical chemistry and haematology historical data in control Sprague-Dawley rats from pre-clinical toxicity studies. Exp Toxicol Pathol 57, 213-219. Podsędek A, Majewska I, Redzynia M, Sosnowska D, Koziołkiewicz M. 2014. In vitro inhibitory effect on digestive enzymes and antioxidant potential of commonly consumed fruits. J Agric Food Chem 62, 4610-4617. Puhl RM, Heuer CA. 2009. The stigma of obesity: a review and update. Obesity 17, 941-964. Qiu P, Guan H, Dong P, Guo S, Zheng J, Li S, Chen Y, Ho CT, Pan MH, McClements DJ, Xiao H. 2011. The inhibitory effects of 5-hydroxy-3,6,7,8,3′,4′-hexamethoxyflavone on human colon cancer cells. Mol Nutr Food Res 10, 1523-1532 Ricci MR, Levin BE. 2003. Ontogeny of diet-induced obesity in selectively bred Sprague-Dawley rats. Am. J. Physiol-Reg. I 285, R610-R618. Roberfroid M, Gibson GR and Delzenne N. 1993. The biochemistry of oligofructose, a nondigestible fiber: an approach to calculate its caloric value. Nutr Rev 51, 137-146. Rodriguez de Sotillo DV, Hadley M, Sotillo JE. 2006. Insulin receptor exon 11+/- is expressed in Zucker (fa/fa) rats, and chlorogenic acid modifies their plasma insulin and liver protein and DNA. J Nutr Biochem 17, 63-71. Rodriguez de Sotillo DV, Hadley M. 2002. Chlorogenic acid modifies plasma and liver concentrations of: cholesterol, triacylglycerol, and minerals in (fa/fa) Zucker rats. J Nutr Biochem 13, 717-726. Rolland V, Roseau S, Fromentin G, Nicolaidis S, Tomé D, Even PC. 2002. Body weight, body composition, and energy metabolism in lean and obese Zucker rats fed soybean oil or butter. Am. J. Clin. Nutr 75, 21-30. Ryu MH, Cha YS. 2003. The effects of a high-fat or high-sucrose diet on serum lipid profiles, hepatic acyl-CoA synthetase, carnitine palmitoyltransferase-I, and the acetyl-CoA carboxylase mRNA levels in rats. J Biochem Mol Biol 36, 312-318. Satouchi M, Wakabayashi S, Ohkuma K, Fujiwara K, Matsuoka A. 1993. Effects of indigestible dextrin on bowel movements. Japanese J. Nutr 51, 31-37. Schrauwen P, Westerterp KR. 2002. The role of high-fat diets and physical activity in the regulation of body weight. Br J Nutr 84, 417-427. Shimoda H, Seki E, Aitani M. 2006. Inhibitory effect of green coffee bean extract on fat accumulation and body weight gain in mice. BMC Complement Altern Med 6, 9. Shishikura Y, Khokhar S, Murray BS. 2006. Effects of tea polyphenols on emulsification of olive oil in a small intestine model system. J Agric Food Chem 54, 1906-1913. Suzuki A, Kagawa D, Ochiai R, Tokimitsu I, Saito I. 2002. Green coffee bean extract and its metabolites have a hypotensive effect in spontaneouslyhypertensive rats. Hypertens Res 25, 99-107. Takeuchi H, Matsuo T, Tokuyama K, Shimomura Y, Suzuki M. 1995. Diet-induced thermogenesis is lower in rats fed a lard diet than in those fed a high oleic acid safflower oil diet, a safflower oil diet or a linseed oil diet. J. Nutr. 125, 920-925. Taylor JB, Calvert CC, Baldwin RL, Sainz RD. 1986. Effects of dietary protein, fat and restriction on body composition and energy balance in lactating rats. J nutri 116, 1519-1528. Trowell H, Southgate DA, Wolever TM, Leeds AR, Gassull MA, Jenkins DJ Letter. 1976. Dietary fibre refined. Lancet 1, 967. Tsuji K, Gordon DT. 1998. Energy value of a mixed glycosidic linked dextrin determined in rats. J. Agric. Food Chem., 46, 2253-2259. Tsujita T, Takaichi H, Takaku T, Aoyama S, Hiraki J. 2006. Antiobesity action of -polylysine, a potent inhibitor of pancreatic lipase. J Lipid Res 47, 1852-1858. Vahouny GV, Cassidy MM. 1986. Dietary fiber and intestinal adaptation, in Dietary Fiber: Basic and Clinical Aspects, Vahouny, G. V. and Kritchevsky, D. Eds., Plenum Press, New York 181-209. Van Loo J, Coussement P, De Leenheer L, Hoebregs H and Smits G. 1995. On the presence of inulin and oligofructose as natural ingredients in the western diet. Crit Rev Food Sci Nutr35, 525-552. Wang Y, Monteiro C, Popkin BM. 2002. Trends of obesity and underweight in older children and adolescents in the United States, Brazil, China, and Russia. Am J Clin Nutr 75, 971-977. Weigle DS. 2003. Pharmacological therapy of obesity: past, present, and future. J Clin Endocrinol Metab 88, 2462-2469. WHO. World Health Organization. 2000. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 894, 1–253. WHO. World Health Organization. 2004. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363, 157-163. WHO. World Health Organization. 2012. Global Health Observatory – the one-stop shop for health data (http://www.who.int/features/2012/global_health_observatory/en/) WHO. World Health Organization. 2016. Obesity and overweight. (http://www.who.int/mediacentre/factsheets/fs311/en/)(accessed Jul 1, 2015) Xiao L, Zhang J, Li H, Liu J, He L, Zhang J, Zhai Y. 2010. Inhibition of adipocyte differentiation and adipogenesis by the traditional chinese herb Sibiraea angustata. Exp Biol Med 235, 1442–1449. Zhu T, Wang L, Wang W, Hu Z, Yu M, Wang K, Cui Z. 2014. Enhanced production of lipstatin from Streptomyces toxytricini by optimizing fermentation conditions and medium. J Gen Appl Microbiol 60,106-111. Zhu YT, Ren XY, Yuan L, Liu YM, Liang J, Liao X., 2015. Fast identification of lipase inhibitors in oolong tea by using lipase functionalised Fe3O4 magnetic nanoparticles coupled with UPLC-MS/MS. Food Chem 173, 521-526.
摘要: 由於生活品質的改善,世界肥胖人口逐漸增加,儼然成為一個全球性重大的健康問題,許多的慢性病的發生原因都可能是肥胖所導致。許多學者致力於降低體脂肪相關的研究,但是誘發肥胖的動物試驗模組方法不一,未探討過飼料配方中脂肪含量比例對於誘發動物肥胖模式的影響。本論文之研究共分為三個部分:第一部分是以飼料配方中不同比例脂肪(23%、40%),輔以含及不含煉乳組別之高脂飲食配方組合之試驗模組比較。第二部分是進行多種不易形成體脂肪纖維配方組合之評估試驗。第三部分是針對較適組合纖維配方進行不易形成體脂肪之評估。經由以上三部分的實驗去探討合適油脂比例誘發高脂動物模式,以及利用水溶性膳食纖維樣品配方組合進行驗證,並評估改善體脂肪之功效。 第一部分的結果發現,23%及40%高脂飲食組添加煉乳後,總攝取熱量及體重增加量皆顯著增加,顯示飼料中加入煉乳,能提升高油脂飼料的適口性;此外,給予大鼠難消化性麥芽糊精的試驗中,由總體脂肪來看,23%脂肪加煉乳組(23 M-C)相較於高脂飲食控制組(HF),低及高劑量難消化性麥芽糊精都有顯著降低體脂肪的效果,但在40%脂肪加煉乳組(40 M-C)效果並不顯著,因此將選擇23%脂肪加煉乳組為誘發動物高脂之最適脂肪比例組合,並進行第二部份的實驗。 第二部分的研究中,分別利用難消化性麥芽糊精(F)、菊糖(I)及多甲氧基類黃酮(P)依不同比例搭配成FI、FP及F2P三組纖維配方,分別為F+I (1:1, w/w)、F+P (1:1, w/w)及F+2P (1:2, w/w),經餵食動物後,FI、FP及F2P各組的總體脂肪量及肝臟三酸甘油酯含量皆較HF組有明顯(p < 0.05)下降趨勢,FI組的糞脂量略高於FP組與F2P組,經綜合評估後推定FI組為較佳組合配方,進入第三部份實驗,並參考衛福部不易形成體脂肪之保健功效評估方法進行商業配方可行性之評估。 第三部分選擇FI組為較適配方組合,以低(HF1X)、中(HF2X)及高(HF3X)三種劑量的實驗組,進行不易形成體脂肪保健功效評估。在體重變化上,各飼料組的最終體重及體重變化量皆高於控制組,再次證明以23% (w/w)油脂加煉乳之高脂肪、高熱量飲食誘導大鼠肥胖之動物模式建立成功。在食物利用率方面,HF2X、HF3X組顯著較HF組為低,表示樣品在減緩體重上的能力較佳,其中以HF3X組有較佳的效果。臟器脂肪方面,HF2X和HF3X相較於HF組有明顯的減少,且具有劑量效應(p < 0.05)。而在總體脂肪的部分,HF2X及HF3X組皆顯著低於HF組,降幅分別約為9.3%及13.7%,下降幅度與劑量呈負相關性。最後觀察各組動物之肝臟脂質濃度及糞便粗脂肪含量,發現前者之HF2X、HF3X相較於HF組有明顯(p < 0.05)的下降趨勢,HF2X、HF3X皆較HF組有較高的糞便粗脂肪排出量,推測樣品能夠減緩飲食中油脂的吸收並藉由糞便排出,進而減少體脂肪的生成。 綜合以上三個部份的實驗結果,以23%脂肪加煉乳之飼料配比可作為有效誘發高脂之實驗模式,利用此模式配合可有效評估水溶性膳食纖維配方之不易形成體脂肪之潛在功效。
The prevalence of obesity in the world has been increasing along with an improvement in the living quality of general public. Obesity may increase the risk of many chronic diseases. Many scientists dedicated themselves to the study of body fat-lowering effect. However, the types of high-fat diet used to induce obesity in animal models are highly variable. Little is known about the effects of fat content in diet on high-fat diet-induced obesity in animal models. For this reason, this study was divided into three parts. In part I, rats were fed diets with different fat contents (23% and 40%) with or without condensed milk in order to compare different formula combinations to induce obesity in animal models. In part II, the body fat-lowering effects of several fiber formulations were evaluated. In part III, the body fat-lowering effects of the comparatively effective fiber formulation in different dosages were evaluated. These experiments were conducted to determine the most appropriate fat content in the diet to induce obesity in animal models, and also to evaluate the body fat-lowering effects of water-soluble dietary fiber in this model. In part I, total energy intake and body weight gain were increased significantly in both groups (23% and 40% fat contents) with condensed milk addition. This result showed that adding condensed milk into diets could increase the palatability of the diets. The presence of resistant maltodextrin in the diet, either in low dose or high dose, could significantly lower total crude body fats in the group fed 23% fat diet with condensed milk addition (23 M-C) as compared with high-fat control group (HF). However, the body fat-lowering effects were not noticeable in the group fed 40% fat diet with condensed milk addition (40 M-C). It was concluded that 23 M-C was the most appropriate fat content of high-fat diet to induce obesity, and therefore it was applied in part II. In part II, resistant maltodextrin (F), inulin (I), and polymethoxylated flavones (F) were combined in different ratios to develop three formulations: FI (F+I with a 1 to 1 ratio, w/w), FP (F+P with a 1 to 1 ratio, w/w), and F2P (F+2P with a 1 to 2 ratio, w/w). The total crude body fats and hepatic triglycerides of rats in groups FI, FP, and F2P were significantly (p < 0.05) decreased compared with those in group HF. From the results, FI was considered as the best formulation among the three groups. Part III was conducted according to the evaluation method of body fat-lowering effects announced by Ministry of Health and Welfare with formulation FI as the sample. In part III, formulation FI was further divided into three dosages: low (HF1X), medium (HF2X), and high (HF3X), then evaluation was done to determine their body-fat lowering effects. Group HF and experimental groups had higher final weights and weight gains than control group, once again proving that 23% fat diet had successfully induced obesity in rats. The feed efficiency of groups HF2X and HF3X were significantly lower than that of HF group, showing that the samples have a better capacity for suppressing body weight gain, with group HF3X demonstrating the best effect among the three groups. Compared with group HF, the visceral fat in groups HF2X and HF3X decreased significantly (p < 0.05) in a dose-dependent manner. Total crude body fats of groups HF2X and HF3X were significantly lower by 9.3% and 13.7%, respectively, compared with that of group HF. Moreover, a negative correlation was observed between dosage and degree of reduction. The lipid concentrations of liver in animals fed HF2X and HF3X diets were lower than those with HF diet significantly (p < 0.05). Fecal fat excretions in groups HF2X and HF3X were also found to be higher than that in group HF. It was inferred that the sample might assist fat excretion through feces so that body fat generation was reduced. In conclusion, diets containing 23% fat and condensed milk could be used as an experimental model to induce obesity in rats. This study demonstrated that this model could be an effective way to evaluate the potential ability of water-soluble dietary fiber formula in body fat reduction.
URI: http://hdl.handle.net/11455/96070
文章公開時間: 10000-01-01
Appears in Collections:食品暨應用生物科技學系

文件中的檔案:

取得全文請前往華藝線上圖書館



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.